Zobrazeno 1 - 10
of 228
pro vyhledávání: '"Ravi, Murthy"'
Autor:
Peiman Habibollahi, Bruno C. Odisio, Varshana Gurusamy, Joshua D. Kuban, Rony Avritscher, Mohamed E. Abdelsalam, Beth A. Chasen, Ravi Murthy, Armeen Mahvash
Publikováno v:
Current Oncology, Vol 29, Iss 12, Pp 9582-9592 (2022)
Purpose: This paper aims to evaluate the safety and efficacy of the temporary redirection of blood flow of hepatoenteric collaterals using a balloon catheter in the common hepatic artery (CHA) to prevent the nontarget deposition of 90Y microspheres.
Externí odkaz:
https://doaj.org/article/b5b8121b81844d74a5baf4b88df23198
Autor:
Ravi Murthy, Alda Tam, Nina M. Muñoz, Malea Williams, Katherine Dixon, Crystal Dupuis, Amanda McWatters, Rony Avritscher, Soraya Zorro Manrique, Kevin McHugh, David Leach, Jeffrey D. Hartgerink, Punit Prakash, Rahul A. Sheth
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 2 (2021)
Background Intratumoral delivery of immunotherapeutics represents a compelling solution to directly address local barriers to tumor immunity. However, we have previously shown that off-target delivery is a substantial problem during intratumoral inje
Externí odkaz:
https://doaj.org/article/7f53a27182084eda9d4c4b3cba2d5e18
Publikováno v:
Case Reports in Radiology, Vol 2021 (2021)
The development of inoperable biliary obstruction in patients with liver, biliary, and pancreatic neoplasia is commonplace particularly in the advanced stages of these diseases. Under these circumstances, restoring bile flow to the gut is paramount i
Externí odkaz:
https://doaj.org/article/d762e018c93a4f63b3ec40a53566233e
Autor:
Sanjay Gupta, Vivek Subbiah, Sapna Patel, Adi Diab, Ravi Murthy, Aung Naing, Funda Meric-Bernstam, Filip Janku, Alda Tam, Timothy Yap, Rahul Sheth
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/451d5f8b751b4b2f8441f39336911a11
Autor:
Vivek Subbiah, Ravi Murthy, Alexander Guminski, Ding Wang, Vivek Bhadri, Nam Bui, Jose Mejia Oneto, Kamalesh Sankhala, M Wayne Saville, Sangeetha Srinivasan, Robert Steffner, Nathan Yee
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/c55cf2e4612745f8907f9de4fc8f5a4c
Autor:
Adi Diab, Chantale Bernatchez, Joseph Markowitz, Igor Puzanov, Gary Doolittle, Sudhir Agrawal, Nashat Gabrail, Patrick Hwu, Willem W. Overwijk, Michael T. Tetzlaff, Denái R. Milton, Srinivas K. Chunduru, Shah Rahimian, Michael A. Davies, Montaser Shaheen, Douglas B. Johnson, Robert H.I. Andtbacka, Marihella James, Houssein Safa, Courtney W. Hudgens, Marc I. Uemura, Salah-Eddine Bentebibel, Ravi Murthy, Daniel H. Johnson, Cara Haymaker
Supplementary Data from Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti–PD-1 Refractory Melanoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::185cb271c5418b269f392ceae19bb35f
https://doi.org/10.1158/2159-8290.22539203.v1
https://doi.org/10.1158/2159-8290.22539203.v1
Autor:
Adi Diab, Chantale Bernatchez, Joseph Markowitz, Igor Puzanov, Gary Doolittle, Sudhir Agrawal, Nashat Gabrail, Patrick Hwu, Willem W. Overwijk, Michael T. Tetzlaff, Denái R. Milton, Srinivas K. Chunduru, Shah Rahimian, Michael A. Davies, Montaser Shaheen, Douglas B. Johnson, Robert H.I. Andtbacka, Marihella James, Houssein Safa, Courtney W. Hudgens, Marc I. Uemura, Salah-Eddine Bentebibel, Ravi Murthy, Daniel H. Johnson, Cara Haymaker
Many patients with advanced melanoma are resistant to immune checkpoint inhibition. In the ILLUMINATE-204 phase I/II trial, we assessed intratumoral tilsotolimod, an investigational Toll-like receptor 9 agonist, with systemic ipilimumab in patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1cbe30284e2c5a973c4196349298f34e
https://doi.org/10.1158/2159-8290.c.6549014.v1
https://doi.org/10.1158/2159-8290.c.6549014.v1
Autor:
Adi Diab, Chantale Bernatchez, Joseph Markowitz, Igor Puzanov, Gary Doolittle, Sudhir Agrawal, Nashat Gabrail, Patrick Hwu, Willem W. Overwijk, Michael T. Tetzlaff, Denái R. Milton, Srinivas K. Chunduru, Shah Rahimian, Michael A. Davies, Montaser Shaheen, Douglas B. Johnson, Robert H.I. Andtbacka, Marihella James, Houssein Safa, Courtney W. Hudgens, Marc I. Uemura, Salah-Eddine Bentebibel, Ravi Murthy, Daniel H. Johnson, Cara Haymaker
Supplementary Table from Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti–PD-1 Refractory Melanoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bb4c1a73b91e0259a3295525b069242
https://doi.org/10.1158/2159-8290.22539194
https://doi.org/10.1158/2159-8290.22539194
Autor:
Igor Puzanov, Adi Diab, Peter M. Anderson, Srinivas Chunduru, Charles Hennemeyer, Gregory Woodhead, Nadia Kaplan, Rolf Hultsch, Ravi Murthy, Chantale Bernatchez, Daruka Mahadevan, Cara Haymaker, Hans Minderman, Shah Rahimian, Daniel Hendler, Corinne Maurice-Dror, Michael Lotem, Jacob Schachter, Alain Algazi, Sanjiv Agarwala, Vivek Subbiah, Erkut Borazanci, Hani Babiker
Supplementary Data from Tilsotolimod Exploits the TLR9 Pathway to Promote Antigen Presentation and Type 1 IFN Signaling in Solid Tumors: A Multicenter International Phase I/II Trial (ILLUMINATE-101)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08b20011d177d7d5a761e08f4d3ceb10
https://doi.org/10.1158/1078-0432.22488717.v1
https://doi.org/10.1158/1078-0432.22488717.v1
Autor:
Igor Puzanov, Adi Diab, Peter M. Anderson, Srinivas Chunduru, Charles Hennemeyer, Gregory Woodhead, Nadia Kaplan, Rolf Hultsch, Ravi Murthy, Chantale Bernatchez, Daruka Mahadevan, Cara Haymaker, Hans Minderman, Shah Rahimian, Daniel Hendler, Corinne Maurice-Dror, Michael Lotem, Jacob Schachter, Alain Algazi, Sanjiv Agarwala, Vivek Subbiah, Erkut Borazanci, Hani Babiker
Purpose:Tilsotolimod is an investigational synthetic Toll-like receptor 9 (TLR9) agonist that has demonstrated antitumor activity in preclinical models. The ILLUMINATE-101 phase I study explored the safety, dose, efficacy, and immune effects of intra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cd4ae721270634e26b1f77adf977a48
https://doi.org/10.1158/1078-0432.c.6532797
https://doi.org/10.1158/1078-0432.c.6532797